AKCA - Akcea Therapeutics Inc. (AKCA) CEO Damien McDevitt on Q2 2020 Results - Earnings Call Transcript
Akcea Therapeutics, Inc. (AKCA)
Q2 2020 Earnings Conference Call
August 4, 2020 16:30 ET
Company Participants
Angelyn Lowe - Executive Director, Corporate Communications & Investor Relations
Damien McDevitt - Director & Chief Executive Officer
Kyle Jenne - Chief Commercial Officer
Michael Price - Chief Financial Officer
Conference Call Participants
Chad Messer - Needham & Company
Jamison Phillips-Crone - BMO Capital Markets
Yaron Werber - Cowen & Company
Presentation
Operator
Good afternoon, and welcome to the Akcea Therapeutics Incorporated Second Quarter 2020 Conference Call. As a reminder, this call is being recorded.
I would now like